Shoemaker, Robert H <br/><br/>
The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets.  [electronic resource] 

 -  Seminars in oncology  Feb 2016 
 - 189-197 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1532-8708 
<br/><br/><label>Standard No.: </label>10.1053/j.seminoncol.2015.09.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anticarcinogenic Agents<br/>Cancer Vaccines<br/>Chemoprevention<br/>Disease Models, Animal<br/>Drug Discovery<br/>Government Programs--organization & administration<br/>Humans<br/>Molecular Targeted Therapy<br/>National Cancer Institute (U.S.)<br/>Neoplasms--prevention & control<br/>Translational Research, Biomedical<br/>United States